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Abstract
Objective To determine whether vitamin A supplementation administered
in the preschool years can lower the risk of hearing loss in adolescence
and adulthood.
Design Follow-up study of adolescents and young adults who, as
preschool aged children in 1989, were enrolled into a cluster randomised,
double blinded, placebo controlled trial of vitamin A supplementation.
Setting South central, rural Nepal.
Participants 2378 adolescents and young adults aged 14 to 23,
representing 51% of those who finished the original trial and 71% of
those living in the study area in 2006.
Interventions Every four months for 16 months preschool children were
visited at home, given an oral 200 000 IU dose of vitamin A (half dose
at age 1-11 months, quarter dose at <1 month) or placebo and the
parents were queried about any childhood illnesses in the previous week,
including purulent discharge from the ears.
Main outcome measures Prevalence of mild or worse hearing loss
(≥30 dB) in the most affected ear and tympanometric measures of middle
ear function (peak height, ear canal volume, and gradient).
Results During the original trial, the prevalence of middle ear infection
during the preschool years did not differ between the supplement groups.
By adolescence and early adulthood, a non-significant 17% reduction
in hearing loss occurred among those who had periodically received
vitamin A compared with placebo as preschool aged children (odds ratio
0.83, 95% confidence interval 0.62 to 1.12). Among participants with
any ear discharge in early childhood, vitamin A supplementation was
associated with a reduced risk of hearing loss, by 42% (0.58, 0.37 to
0.92) compared with controls, after adjusting the confidence interval for
the design effect of the original trial. Abnormal tympanometric peak
height of the middle ear system was less likely among participants
supplemented with vitamin A in childhood.
Conclusion In undernourished settings, periodic, high dose vitamin A
supplementation may reduce the risk of hearing loss associated with
purulent ear infections in early childhood.
Introduction
Hearing loss severe enough to disrupt communication and
socialisationaffectsanestimated278millionpeopleworldwide,
two thirds of whom live in the developing world.
1 2 Hearing
disability limits economic and educational opportunities,
3 4
especiallyinlowincomecountrieswhererehabilitationservices
are lacking.
2 4 Most hearing loss among children living in
poverty is attributable to chronic otitis media.
2
There is limited epidemiological evidence that deficiencies in
certain nutrients, such as iron, zinc, copper, calcium, and
vitaminsAandD,mayincreasesusceptibilitytoearinfections,
5
andthatsupplementationwithmicronutrientsinundernourished
settings may attenuate the risk of otitis media in children. For
example, two supplementation trials among preschool aged
children, in Bangladesh
6 and Kenya,
7 reported reductions in
otitismediaafterroutinesupplementationwithzincandvitamin
A, respectively. Both nutrients regulate numerous metabolic
pathways involved in host defence mechanisms,
5 which when
compromisedcouldincreasethefrequency,duration,orseverity
of ear infections that, in turn, could increase the risk of hearing
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Research
RESEARCHloss. No trials to our knowledge have followed participants to
assesstheeffectofnutritionalsupplementationonhearingloss.
SouthernAsiaisarelevantregioninwhichtoexplorethecausal
association and public health impact of vitamin A deficiency
on hearing loss, as both conditions coexist and are widely
prevalent. The prevalence of vitamin A deficiency in southern
Asia is about 33%, and approximately 45% of vitamin A
deficient preschool children in the world reside in the region.
8
The World Health Organization estimates that chronic otitis
mediaaffectsbetween1.4%and7.8%ofchildreninSouthEast
Asia.
9 Within Nepal, vitamin A deficiency affects an estimated
32% of preschool children,
10 and 8% of children aged 5 to 15
years have a diagnosis of hearing loss.
11 Abnormal
tympanometry in either ear, often attributable to current or past
otitis media, has been estimated to affect 25% of young people
in the country.
12
In the present study, in Nepal, we examined the causal effect
of randomised, periodic receipt of high dose (200 000 IU)
vitamin A during the preschool years on hearing loss in early
adulthood. We hypothesised that discharge from the ears,
prospectively monitored during early childhood, would be
positively associated with hearing loss, and that vitamin A
supplementation during that early period would lower this risk
by attenuating the frequency, duration, or severity of middle
ear infection compared with a group randomised to placebo in
early childhood.
Methods
Wecarriedoutastudyofearhealthandhearingamongacohort
of adolescents and young adults aged 14 to 23 and living in the
Sarlahi district of south central Nepal. In their preschool years
these participants had taken part in a double blinded, placebo
controlledclusterrandomisedtrialofvitaminAsupplementation
(NNIPS-1, the first trial of the Nepal Nutrition Intervention
Project-Sarlahi) between 1989 and 1991.
13
Original trial
During the original trial, 261 administrative wards in the 29
contiguous village development communities in Sarlahi were
randomised, blocked on contiguous village development
communities. Preschool children were to receive a vitamin A
supplement (200 000 IU for children aged 12 months or older,
100 000 IU for 1 to 11 months, and 50 000 IU for <1 month)
or an identical placebo capsule (containing 1000 IU vitamin A)
during home visits every four months.
Duringabaselinevisit(SeptembertoDecember1989),children
aged 60 months or younger were enumerated, dosed with
supplements assigned by ward, measured for mid-upper arm
circumference to reflect nutritional status, and evaluated for
morbidity by parental interview about the number of days in
thepastweekinwhichthechildwasreportedtohavehadfever,
cough, loose watery or bloody stools, or discharge of pus from
either ear (an indicator of middle ear infection). To improve
reliability, morbidity histories were recorded only if children
had been with their parent or guardian for the previous seven
days,aconditionmetbyabout90%ofrespondentsateachvisit.
Supplementationandanthropometricandmorbidityassessments
were repeated during home visits every four months, during
which new infants were also recruited into the trial. Household
socioeconomic and demographic information was recorded at
the time of the second of the four-monthly visits. Although
originally planned for two years, the trial was stopped after 16
months for children aged 6 months or older after a data and
safety monitoring analysis showed a highly significant 30%
reduction in mortality attributed to vitamin A.
13 Thereafter,
childrenaged6monthsorolderreceivedahighdoseofvitamin
A, whereas infants enrolled for a subsequent year remained in
the trial up to 6 months of age.
Trial substudy cohort
A subset of 40 (15%) of the 261 enlisted wards, 20 per
supplement group, was randomly selected for enrolled children
toreceiveadditionalnutritionalandhealthassessmentsatcentral
sites, including an otoscopic examination of the ear by a doctor
at the first and fifth visits. The examination, carried out blinded
to the findings by parental history, enabled the history of ear
discharge to be validated against clinical appearance recorded
onthesameday,whichshowedexcellentagreement(κ=0.75).
14
Participants in the present study were members of the baseline
cohort of preschool children aged less than 5 at enrolment, who
hadbeenmaximallyexposedtothenutrientsupplementprotocol
(five 200 000 IU of vitamin A v placebo) and the risk of
acquiringadetectable,preschoolearinfectionduringtheperiod
of the trial (five examinations over a 16 month period). To
maximise our ability to accurately classify the status of ear
discharge during the trial, we excluded participants with 60%
ormoreincompletedataoneardischarge—thatis,childrenwith
three, four, or all five of their reports on ear discharge missing.
Follow-up study
Participants known to have survived to the end of all data
collection activities related to the trial in 1992 were listed by
the Nepal Nutrition Intervention Project-Sarlahi project’s data
management centre. This list enabled confirmation of the
identity and residential and vital status of participants at the
outset of a health and nutrition assessment of the cohort in
2006-8. At an initial follow-up home visit, original trial staff,
whoremainedcontinuouslyemployedbytheprojectduringthe
interim, obtained informed consent and updated data on
individual vital status, residency, marriage, schooling,
occupation, and (for females) pregnancy status, as well as
household socioeconomic status. From these home visits, we
identified potential contacts who provided the list of cohort
members sought for follow-up assessment.
Afterascertainmentofvitalstatus,wecarriedoutanassessment
of ear health and hearing by previously described methods at a
convenient central site in each ward.
12 Technicians, blinded to
the original supplement allocation of the ward, carried out the
ear examinations and hearing assessments. Ear wax was not
removed before the examination. Technicians examined the
externalear,tympanicmembrane,andmiddleearusingalighted
otoscope (mini 2000 otoscope; Heine, Herrsching, Germany).
Earhealthandfunctionweremeasuredthroughtympanometric
measurementstakenatvariedairpressurelevelsusingaportable
tympanometer(MicroTymp2;Welch-Allyn,SkaneatelesFalls,
NY), which varied the pressure in the ear canal from 200 to
−400 decapascals (daPa), providing data on admittance of the
middle ear system (peak height and gradient) and ear canal
volumeat200daPa.Audiometrywascarriedoutusingadigital
audiometer (240 digital audiometer; Amplivox, Oxford, UK)
and foam tipped insert earphones (Auditory System; E-A-R,
Indianapolis, IN). Participants were considered to have failed
hearing screening if they did not respond to a 30 decibel (dB)
tone in either ear at any of the frequencies of 0.5, 1, 2, 4, and 8
kilohertz (kHz).
12 Participants who failed the screening were
tested to establish air conduction thresholds at 0.5, 1, 2, 4, and
8 kHz in both ears.
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RESEARCHWe used a two staged measure of hearing disability as the
primary outcome: screening failure and hearing loss, defined
asameanofthresholdvaluesforairconductionat0.5,1,2,and
4 kHz greater than or equal to 30 dB in the worst affected ear
among those who failed screening.
12 This definition represents
a deficit in hearing at the middle frequencies that is commonly
used in audiology and is widely associated with difficulties in
communication.
15-17
Statistical analysis
We used the χ
2 test to compare supplementation groups on
personal and household factors measured at the baseline visit
of the original trial and at the follow-up study 17 years later.
Differences in risk of failing screening and exhibiting hearing
loss in adolescents and young adults in the supplementation
groups were estimated by the odds ratio and absolute risk
difference. Since supplementation was originally allocated by
cluster (ward), we adjusted 95% confidence intervals using
generalisedestimatingequationsregressionmodels,
18specified
as binomial with an identity and logit link for absolute risk
difference and odds ratio estimates,
19 respectively, and
exchangeable correlation structure.
Because of the potential for imbalance between groups
associated with losses to follow-up in the intervening years and
non-responseamongre-contactedparticipants,wealsoadjusted
odds ratios and absolute risk differences for several covariates
using sequential multivariable logistic regression analyses.
20
Age and sex were included in the full models. We considered
variables as potential confounders and included them in the
modelifassociated(P<0.10)witheithersupplementationgroup
allocation or hearing status. All analyses were done using
STATA, version 10.0, software.
Results
In total, 4765 children from newborn to 60 months of age were
recruited into the baseline cohort substudy area of the original
trial; 2507 (52.6%) were allocated by ward to receive vitamin
Aand2258(47.4%)toreceiveplacebo(fig1⇓).Fortythreeand
52 children, respectively, died between the baseline (first) and
fifth visits of the original trial. During the next 16 years, 172
children died (100 in vitamin A group and 72 in placebo group)
and1138(622and516,respectively)hadmovedfromthestudy
area, leaving 71% (1742 in vitamin A group) and 73% (1618
inplacebogroup)oftheoriginalcohortsaspotentialparticipants.
Of these, 86% and 83% of participants in each group were
contacted and 75% (1304 in vitamin A group) and 72% (1165
in placebo group) examined and tested for hearing in 2006-8.
Respondents in both supplementation groups were comparable
on a wide range of household socioeconomic (table 1⇓) and
personal(table2⇓)characteristics,asassessedduringtheoriginal
trial and the follow-up study. No systematic patterns were
apparent among the few differences observed between
participants of each original supplement group who were
followed-up. Slightly fewer heads of households reported
completing secondary education and having farming as their
occupation in the vitamin A group than placebo group, with the
occupational difference persisting among the adolescents and
young adults at follow-up. Fewer females were tested at
follow-up in both groups, reflecting a pattern of young women
marrying and leaving home earlier in life than young men.
21
During the five four-monthly visits of the trial, about 19% of
participants reported at least one episode of discharging pus in
eitherearduringthepreviousweek;about45%ofthesereported
two or more positive episodes. Around 72% of reports on ear
discharge were for seven or more days, and 38% to 52% of
cases during any given visit reported having discharge on the
next visit (data not shown), seeming to reflect the chronicity of
purulent episodes. Vitamin A supplementation seemed to have
no effect on the prevalence of weekly ear discharge during the
trial (table 2).
At follow-up, the prevalence of screening failure and hearing
lossamongparticipantswas11.7%(278/2373)(95%confidence
interval 10.4% to 13.0%; table 3⇓) and 5.9% (140/2370) (5.0%
to 6.9%; table 4⇓), respectively. Risk of hearing loss was
associated with reported episodes of ear discharge in a
dose-response relation, with the odds ratio increasing from 2 to
17 as the number of reported childhood weekly episodes of ear
discharge (one or more days with symptoms in the previous
week) increased, compared with those reporting no episodes
(fig2⇓).Alloddsratiosand95%confidenceintervals,adjusted
for original design effect, excluded 1.0. Virtually the same
pattern was observed for screening failure (data not shown).
Tables 3 and 4 present the findings on effects of preschool
vitamin A supplementation on risks of failing screening and
hearing loss, respectively. Compared with placebo, receipt of
vitamin A had no overall effect on the risk of failing screening
(oddsratio0.97,95%confidenceinterval0.69to1.35;absolute
riskdifference−0.3%,95%confidenceinterval−3.9%to3.2%),
but seemed to reduce the risk of hearing loss, by 17% (0.83,
0.62 to 1.12; −1.0%, −2.7% to 0.7%). Among participants
withoutreportedeardischargeoveranyofthefivefour-monthly
weekly reports, preschool vitamin A supplementation had no
effect on the risk either of failing screening (1.17, 0.78 to 1.76;
1.2%,−1.9%to4.2%)orhearingloss(1.07,0.64to1.80;0.2%,
−1.5% to 1.9%). Among children with any preschool ear
discharge(oneinfivetimesormore),theoddsratioandabsolute
risk difference estimates were 0.71 (0.44 to 1.14) and −6.8%
(−16.4% to 2.7%) for failure of hearing screening, and 0.58
(0.37 to 0.92) and −7.2% (−13.0% to −1.4%) for hearing loss,
respectively. Multivariable analysis (adjusting for design, sex,
age at enrolment into the original trial, caste, and head of
householdoccupation),resultedinvirtuallyidenticaloddsratios
of 0.69 (0.42 to 1.13) for failure of hearing screening and 0.58
(0.38to0.89)forhearinglossamongparticipantswithahistory
of ear discharge and allocated to receive preschool vitamin A
compared with placebo in early childhood.(data not shown).
We assessed the impact of vitamin A on hearing loss for two
aspects of severity, one related to ear discharge and the other
to extent of hearing loss. There was no evidence of increased
protection against ear discharge by vitamin A on hearing loss
by the number of ear discharge reports in early childhood: the
odds ratio for screening failure and hearing loss in vitamin A
compared with placebo recipients for one reported episode was
0.44 (95% confidence interval 0.19 to 1.04) and 0.28 (0.09 to
0.85) and for two to five episodes was 0.79 (0.44 to 1.42) and
0.76(0.44to1.33),respectively.Wetestedtheextentofhearing
loss by applying a more stringent threshold of greater than 40
dB for defining hearing loss in the worst affected ear. Against
this cut-off, the protective odds ratio against hearing loss was
stronger, 0.42 (0.21 to 0.82), although the absolute rates, 5.0%
(12/242) and 10.8% (23/214) and absolute risk difference
(−5.9%, 95% confidence interval −9.9% to −2.2%) did not
widen (data not shown).
Tympanometry revealed a lower odds ratio of having an
abnormal tympanic membrane peak height associated with
previous receipt of vitamin A (odds ratio 0.83, 95% confidence
interval 0.67 to 1.03), with estimates close to one for gradient
(odds ratio 0.97) and volume (0.95; table 5⇓). Stratification
revealedsimilarestimatesforoddsratiosinparticipantswithout
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RESEARCHand with preschool ear discharge for peak height and gradient,
although odds ratios related to volume varied qualitatively. All
95% confidence intervals included 1.0.
Discussion
In this chronically undernourished rural South Asian setting,
periodic, high dose vitamin A supplementation in early
childhoodsignificantlyreducedtherelativeoddsofhearingloss
associated with early childhood middle ear infection by 42%.
This effect translated into a significant 7% absolute reduction
in hearing loss, from 20%, among those known to have had
early childhood ear discharge, and about a 1% absolute (17%
relative) decline, from 6.5% to 5.4%, in hearing loss from all
causes. Although suggestive from the literature over the past
80 years,
5 22 23 to our knowledge this is the first study to show
protectionconferredbyvitaminAagainsthearinglossoflikely
infectious origin.
Context of vitamin A effect
This latent effect of vitamin A supplementation was observed
in a vitamin A deficient rural setting. At the outset of the trial,
around1990,theprevalenceofxerophthalmiawasabout3.5%,
24
reflecting ocular manifestations of vitamin A deficiency, later
affirmed by a national survey reporting 33% of preschool
children in the subtropical plains of southern Nepal to have
hyporetinolaemia
10 (serum retinol concentration below the
conventional cut-off for deficiency of 0.70 µmol/L; referent
median, 5th-95th percentiles for 4-8 years: 1.20, 0.84 to 1.58
µmol/L).
25 Both estimates classify this population as vitamin A
deficient.
26 The public health burden of vitamin A deficiency
was further shown by the 30% reduction in mortality among
children who received vitamin A in the original trial.
13 Purulent
ear infection was a common childhood condition, as reported
by a clinically validated parental history,
14 affecting 20% of
participants in the population cohort, half of whom reported
having had a discharging ear on at least two occasions (table
2).Althoughthetwogroupsdidnotdifferinweeklyprevalence
ofeardischarge,childmortalityafteranacuteepisode(discharge
for<7daysbutnotlonger)wasnoticeablyreducedwithvitamin
A supplementation, evident by a protective odds of 0.24 (95%
confidence interval 0.07 to 0.80) compared with recipients of
placebo (K P West Jr et al, unpublished data, 2011).
The effect of vitamin A was observed in a population where, in
2006-8, hearing loss in either ear affected 6.5% of adolescents
and young adults—that is, those who had received placebo
during the original trial. This frequency is comparable to a
prevalence of 8.3% reported from a hearing survey carried out
in the terai in the mid-90s among children aged 5-15 years,
11
before the launch of the country’s national vitamin A
programme. Against this stable prevalence, the observed 42%
reduction in hearing loss due to ear discharge in the vitamin A
recipient group provides a basis for the 17% overall reduction
to be interpreted as the fraction of mild or worse hearing loss
that should be preventable by a programme for vitamin A
supplementation in preschool children.
Biological plausibility
The protective effect of vitamin A we observed is posited to
have occurred through a reduction in the severity of middle ear
infection by host defence mechanisms, regulated by vitamin
A,
27-29 that are involved in maintaining epithelial integrity,
modulating oxidative stress, and regulating the immune
response, thereby controlling inflammatory processes that may
damage the ear and impair hearing. Possibly central to each
mechanism is the regulatory influence of vitamin A on cell
proliferation, differentiation, and apoptosis, as exerted through
its nuclear receptors ongeneexpressionandprotein synthesis.
30
Experimental vitamin A deficiency leads to a loss in integrity
of normally ciliated, mucus secreting epithelium in the middle
ear, a degradative process characterised by keratinising
metaplasia, oedema, and inflammation.
31-33 Other pathological
changes may include a degeneration of auditory nerves and
cochlea and overgrowth of ossicular bone.
33 However, treating
experimentalotitismediaorsinusitiswithvitaminAinanimals
has been shown to reduce mucosal disruption, enhance
antioxidantenzymeactivity(forexample,superoxidedismutase
and glutathione peroxidase), and lower free radical production
(for example, lower concentrations of malondialdehyde and
nitric oxide).
34-36 Vitamin A modulates innate and adaptive
immune responses to infection,
29 favouring Th2-type, T
regulatory, and apoptotic pathways that may be expected to
control inflammation, oxidative stress, and consequent tissue
destruction
37 and that may reduce the risk of long term
suppurative, ossicular, and tympanic damage.
5 Studies in
nutritionallyvulnerablepopulationshavereportedthatchildren
with acute otitis media have disturbed antioxidant enzyme
activity and tend to have low antioxidant nutrient status,
38-40
including vitamin A deficiency,
22 39 41 42 conditions that may
favouraninappropriateorlesscontrolledinflammatoryresponse
to middle ear infection. One trial, among Kenyan children
admitted to hospital for measles, observed a 74% decline (95%
confidence interval 8% to 95%) in incident otitis media among
participantsrandomisedtolargedosevitaminAcomparedwith
placebo on admission,
7 but the children were not followed for
hearing loss.
Clinical coherence
Weevaluatedtheconsistencyoftheprotectiveeffectofvitamin
A against hearing loss for tympanometric findings and
response-gradient thresholds. Hearing loss in this population
was accompanied by ear drum dysfunction, as measured by
abnormal membrane peak height, gradient, or volume.
12
However, only in peak height was improved function in
participants supplemented with vitamin A compared with
placebo suggested, irrespective of ear discharge in early
childhood.Althoughunexpected,comparabletympanicfunction
may still be compatible with improved hearing among vitamin
A supplemented cases, given that membrane lesions resulting
from otitis media in early life may recover,
43 and, aside from
conductive loss related to disturbance of the ear drum, middle
ear infection may also induce sensorineural hearing loss by
disturbing cochlear function,
44 hair cell loss, and other diseases
within the inner and middle ear,
45 not observed with
tympanometry. Finally, with a quarter of participants having
abnormal tympanometry,
12 further injurious exposures under
harsh, rural conditions in the interim years could have negated
potential tympanic differences between groups.
We also assessed the protective response of vitamin A for
apparentseverityofhearinglossinadolescentsandyoungadults
and ear discharge in early childhood. There was a stronger,
protective relative odds of vitamin A against hearing loss when
the tone threshold was increased from 30 dB (odds ratio 0.58)
to a more stringent cut-off of more than 40 dB (0.42). The
finding is consistent with stronger protective risks ascribed to
vitamin A in other trials by using more stringent definitions of
infections such as diarrhoea, measured as number of stools
daily,
46 47 or severity of general illness based on level of care
sought.
47 However, although the risk of hearing loss increased
with the frequency of ear discharge during the original trial (fig
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RESEARCH2), we failed to observe a parallel gradient in protection with
vitamin A. One explanation may be that the therapeutic action
of vitamin A occurs during the early, acute inflammatory phase
rather than the chronic or recurrent periods of purulent ear
infection.Alternatively,thelackofadose-responseeffectcould
have occurred by chance given the breadth of confidence
intervals around the odds ratios related to one or more than one
week of reported ear discharge.
Completeness of follow-up
An a priori hypothesis was tested in this study that was
established during the original trial’s design, based on earlier
reports of an association between vitamin A deficiency and
otitismedia.
22 23 42Inacohortrandomisedtoanexposureinearly
life, high rates of follow-up permit an inference about cause
and effect to be drawn.
48 In each group, we evaluated hearing
in about 51% of participants believed to have survived the 16
interimyearssincetheendofthetrialandin71%ofparticipants
consideredpotentiallycontactableinthestudyarea.About15%
of those considered as potential participants could not be found
with repeated visits, suggesting emigration from the area.
Despitelossestofollow-up,internalvaliditypossiblyprotected
on the basis of comparability in the proportionate losses from
each group and the similarity of assessed individuals in each
grouponnumerouscharacteristicsevaluatedduringtheoriginal
trial and at the time of follow-up. With respect to external
validity,althoughparticipantsassessedasadolescentsandyoung
adults in both groups differed in several ways from those not
followed, it does not seem that factors for which imbalances
were observed (sex, socioeconomic status, and age) were, in
this population, associated with either a history of purulent ear
infectionorcurrenthearing,suggestinglowprobabilitiesofbias
associated with losses to follow-up.
Strengths and limitations of the study
Carrying out hearing assessments in open, rural community
settings, rather than in a sound proofed clinic, challenges the
control of ambient sound and accuracy of testing. However, we
believe the integrity of our testing protocol was enhanced by
using insert earphones, an accessory that attenuates ambient
noise,andpausingorrestartinghearingteststhatweredisturbed
byobvioussounds.Tofacilitatemonitoringoftheambientnoise
levels we used a sound level meter. Supplements during the
initial double blinded, randomised trial were taken with high
compliance (>90%) in both the vitamin A and placebo groups,
providingassuranceofintendednutritionalexposure.Multiple,
prospective assessments of ear discharge over a consecutive 16
month period enabled the occurrence of ear discharge to be
monitored for a substantial period of early childhood.
Measurement bias was minimised by assuring that field
technicians doing the hearing tests and examinations were
blinded to the original supplementation assignment of each
community.
Conclusions and policy implications
In this rural Nepalese population, periodic, high dose vitamin
A supplementation in early childhood was associated with a
reduction in the risk of hearing loss from middle ear infection
inadolescenceandyoungadulthood.Levelsofdetectedhearing
lossweremildorworseinthemostaffectedear,andsufficiently
severe to disrupt normal activities of daily living and
socialisation.
12Tothedegreesthatrisksofearinfection,vitamin
A deficiency, and hearing impairment observed in the terai of
Nepal coexist elsewhere in rural South Asia, current, ongoing
programmes for vitamin A supplementation in preschool
children designed and intended to prevent xerophthalmia
49 and
childmortality
13maybesubstantiallyattenuatingrisksofhearing
loss in the region, providing an additional public health
indicationforvitaminAprophylaxisinearlychildhoodinareas
of high deficiency.
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RESEARCHTables
Table 1| Household characteristics of adolescents and young adults at time of original trial and follow-up study by supplement allocation
in Sarlahi, Nepal, 2006-8
No (%) in placebo group (n=1119) No (%) in vitamin A group (n=1259) Characteristics
Baseline
224 (20.0) 293 (23.3) Higher caste (Brahmin or Chettri)
502 (44.9) 581 (46.1) Literate head of household
Occupation of head of household*:
812 (72.6) 822 (65.3) Farmer
195 (17.4) 219 (17.4) Labourer
112 (10.0) 218 (17.3) Private, business, or government
100 (8.9) 83 (6.6) Head of household completed secondary school***:
588 (52.5) 669 (53.1) >1 living room in house
559 (50.0) 625 (49.6) Tube well water source
68 (6.1) 71 (5.6) Latrine in home
Ownership:
296 (26.5) 343 (27.2) Watch
913 (81.6) 990 (78.6) Land
237 (21.2) 273 (21.7) Bicycle
259 (23.1) 318 (25.3) Radio
Follow-up
577 (51.9) 697 (55.8) Pahadi ethnic group
934 (84.1) 1032 (82.6) >1 living room in house
903 (81.4) 990 (79.2) Tube well water source
266 (24.0) 302 (24.2) Latrine in home
Ownership:
700 (63.1) 804 (64.5) Watch
911 (82.2) 1058 (84.6) Land
808 (72.9) 914 (73.1) Bicycle
563 (50.8) 591 (47.3) Radio
Baseline variables missing for literacy (placebo n=1). Missing data on follow-up variables: ethnic group (vitamin A=10, placebo=8), rooms (vitamin A=9, placebo=8),
water source (vitamin A=9, placebo=9), latrine (vitamin A=9, placebo=10), watch ownership (vitamin A=12, placebo=10), land ownership (vitamin A=9, placebo=11),
bicycle ownership (vitamin A=9, placebo=10), radio ownership (vitamin A=9, placebo=10).
*P<0.05 by χ
2 test.
***P<0.001 by χ
2 test.
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RESEARCHTable 2| Personal characteristics of adolescents and young adults at time of original trial and follow-up study by supplement allocation in
Sarlahi, Nepal, 2006-8
No (%) in placebo group (n=1119) No (%) in vitamin A group (n=1259) Characteristics
Baseline
Sex:
678 (60.6) 740 (58.8) Male
441 (39.4) 519 (41.2) Female
Age at baseline (months):
232 (20.7) 266 (21.1) <12
887 (79.3) 993 (78.9) 12-60
No of visits with capsule administered directly:
5 (0.5) 8 (0.6) ≤2
300 (26.8) 345 (27.4) 3-4
814 (72.7) 906 (72.7) 5
MUAC z score at baseline visit*:
267 (23.9) 286 (22.7) <−2
849 (76.1) 972 (77.3) ≥−2
Prevalent episodes of ear discharge†:
904 (80.8) 1015 (80.6) 0
119 (10.6) 130 (10.3) 1
39 (3.5) 45 (3.6) 2
24 (2.1) 28 (2.2) 3
19 (1.7) 31 (2.5) 4
14 (1.3) 10 (0.8) 5
Follow-up
776 (74.3) 915 (76.2) Literate
Occupation‡:
117 (11.2) 144 (12.0) In-home
277 (26.5) 267 (22.2) Farmer
146 (14.0) 156 (13.0) Labourer
83 (8.0) 139 (11.6) Private, business, or government
421 (40.3) 495 (41.2) Student
366 (35.0) 449 (37.4) Completed secondary school
325 (31.1) 347 (28.9) Married
MUAC=mid-upper arm circumference.
Missing data for baseline variables: arm circumference (placebo n=3 and vitamin A n=1), ear discharge episode reports (placebo n=250 and vitamin A n=257).
Missing data on follow-up variables: literacy, marital status, occupation and education (placebo n=74 or 75 and vitamin A n=58 for each).
*MUAC z score calculated using 2006 WHO child growth standards.
50
†Positive weekly reports of ear discharge in child collected by parental history every four months during original trial, 1989-91.
‡P<0.05 by χ
2 test.
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RESEARCHTable 3| Odds ratios and absolute risk differences for failure of hearing screening test* among adolescents and young adults by preschool
allocation of supplements in Sarlahi, Nepal, 2006-8
% absolute risk difference† (95% CI) Odds ratio† (95% CI) No (%) Total No Supplement allocation
— — 278 (11.7‡) 2373 Overall:
— 1.00 134 (12.0) 1117 Placebo
−0.3 (−3.9 to 3.2) 0.97 (0.69 to 1.35) 144 (11.5) 1256 Vitamin A
No ear discharge:
— 1.00 67 (7.4) 902 Placebo
1.2 (−1.9 to 4.2) 1.17 (0.78 to 1.76) 88 (8.7) 1012 Vitamin A
Any ear discharge:
— 1.00 67 (31.2) 215 Placebo
−6.8 (−16.4 to 2.7) 0.71 (0.44 to 1.14) 56 (23.0) 244 Vitamin A
*Defined as not responding to a 30 dB tone in either ear at frequencies 0.5, 1, 2, 4, or 8 kHz.
†Estimates account for cluster randomised design of supplement allocation in original trial (1989-91) using generalised estimating equations method.
18
‡95% confidence interval 10.4% to 13.0%.
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RESEARCHTable 4| Odds ratios and absolute risk differences for hearing loss* among adolescents and young adults by preschool supplement
allocation in Sarlahi, Nepal, 2006-8
% absolute risk difference‡ (95%
CI) Odds ratio‡ (95% CI) No (%) Total No Supplement allocation
— — 140 (5.9†) 2370 Overall:
— 1.00 72 (6.5) 1116 Placebo
−1.0 (−2.7 to 0.7) 0.83 (0.62 to 1.12) 68 (5.4) 1254 Vitamin A
No ear discharge:
— 1.00 30 (3.3) 902 Placebo
0.2 (−1.5 to 1.9) 1.07 (0.64 to 1.80) 36 (3.6) 1012 Vitamin A
Any ear discharge:
— 1.00 42 (19.6) 214 Placebo
−7.2 (−13.0 to −1.4) 0.58 (0.37 to 0.92) 32 (13.2) 242 Vitamin A
*Defined as mean of air conduction threshold values at 0.5, 1, 2, and 4 kHz ≥30 dB in worse affected ear among participants who failed hearing screening test.
†95% confidence interval 5.0% to 6.9%.
‡Odds ratio and absolute risk difference estimates account for cluster randomised design of supplement allocation in original placebo controlled vitamin A trial
(1989-91) using generalised estimating equations method.
18
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RESEARCHTable 5| Adjusted odds ratios for tympanometric dysfunction* among adolescents and young adults by preschool supplement allocation
(n=2364) in Sarlahi, Nepal, 2006-8
Odds ratio† (95% CI)
Supplement allocation Abnormal volume Abnormal gradient Abnormal peak height‡
Overall:
1.00 1.00 1.00 Placebo
0.95 (0.69 to 1.31) 0.97 (0.70 to 1.35) 0.83 (0.67 to 1.03) Vitamin A
No ear discharge:
1.00 1.00 1.00 Placebo
0.82 (0.56 to 1.20) 1.13 (0.71 to 1.79) 0.85 (0.65 to 1.10) Vitamin A
Any ear discharge:
1.00 1.00 1.00 Placebo
1.45 (0.94 to 2.25) 0.89 (0.51 to 1.53) 0.83 (0.52 to 1.31) Vitamin A
*Defined as abnormal low or high peak height (<0.3 or >1.4 millimho), an abnormally wide gradient or low or high volume (<0.6 or >1.5 cm
3).
†Estimates account for cluster randomised design of supplement allocation using generalised estimating equations method and are adjusted for sex, age (months),
occupation of head of household, and caste of household during original trial.
‡Missing data for peak height (n=5) and gradient (n=4).
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RESEARCHFigures
Fig 1 Flow of participants through trials
Fig 2 Relative odds of hearing loss in adolescents and young adults by reported frequency of ear discharge in preschool
years, Sarlahi, Nepal 2006-8. Odds ratios (95% CI) expressed on natural log scale. Hearing loss defined as mean of air
conduction threshold values at 0.5, 1, 2, and 4 kHz ≥30 dB in worst affected ear
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